AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 95 filers reported holding AVIDITY BIOSCIENCES INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $418,873 | -50.6% | 65,654 | -14.1% | 0.00% | 0.0% |
| Q2 2023 | $848,008 | -22.2% | 76,466 | +7.7% | 0.00% | -50.0% |
| Q1 2023 | $1,089,528 | -27.4% | 70,979 | +5.0% | 0.00% | 0.0% |
| Q4 2022 | $1,499,778 | +75.4% | 67,588 | +29.1% | 0.00% | +100.0% |
| Q3 2022 | $855,000 | +16.0% | 52,339 | +3.2% | 0.00% | 0.0% |
| Q2 2022 | $737,000 | -13.1% | 50,698 | +10.4% | 0.00% | 0.0% |
| Q1 2022 | $848,000 | -27.5% | 45,931 | -6.6% | 0.00% | 0.0% |
| Q4 2021 | $1,169,000 | -2.0% | 49,183 | +1.6% | 0.00% | -50.0% |
| Q3 2021 | $1,193,000 | +15.6% | 48,422 | +16.0% | 0.00% | +100.0% |
| Q2 2021 | $1,032,000 | +2.9% | 41,755 | -9.2% | 0.00% | 0.0% |
| Q1 2021 | $1,003,000 | +55.3% | 45,987 | +81.7% | 0.00% | 0.0% |
| Q4 2020 | $646,000 | -9.4% | 25,311 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $713,000 | – | 25,311 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 825,473 | $18,317,246 | 17.56% |
| COWEN AND COMPANY, LLC | 4,288,366 | $95,158,841 | 9.95% |
| Cormorant Asset Management, LP | 2,762,115 | $61,291 | 4.10% |
| 5AM Venture Management, LLC | 665,555 | $14,768,665 | 3.97% |
| RTW INVESTMENTS, LP | 5,605,566 | $124,387,510 | 2.54% |
| RA Capital Management | 5,454,533 | $121,036,087 | 2.46% |
| COMMODORE CAPITAL LP | 590,705 | $13,108 | 1.98% |
| Avidity Partners Management LP | 3,275,000 | $72,672,250 | 1.57% |
| Casdin Capital, LLC | 850,000 | $18,861,500 | 1.46% |
| Boxer Capital, LLC | 1,121,327 | $24,882,246 | 1.31% |